Summary. Progestagen-concentrating cells were localized in the oestrogen-primed ovariectomized galago by radioautography after injection of [3H]promegestone (R5020). In the brain, radioactivity was concentrated in the nuclei of neurones in the preoptic region and in the mediobasal hypothalamus. Labelled cells were also observed in the anterior pituitary. In the uterus (uterine horns and cervix), the muscle and stromal cells showed greater labelling than did the glandular and luminal epithelia. Labelled cells were present in the different cell layers of the vagina. The majority of glandular epithelial cells of the mammary glands exhibited a high degree of labelling.
Introduction
Cytoplasmic and nuclear progestagen receptors have been identified in the central nervous system and in the uterus of the rat (Kato&Onouchi, 1977;  Moguilewsky & Raynaud, 1977 & Raynaud, ,1979a Kato, Onouchi & Okinaga, 1978; Vu Hai & Milgrom, 1978a, b; MacLusky & McEwen, 1978 , 1980 Blaustein & Wade, 1978; Seiki, Haruki, Imanishi & Enomoto, 1979; Haruki, Seiki & Imanishi, 1980) and of the monkey (MacLusky, Lieberburg, Krey & McEwen, 1980; Garrís, Billiar, Takaoka, White & Little, 1981) . The concentration of these receptors increased after oestrogen treatment in the hypothalamus, pituitary and uterus. Progestagen binding sites have also been demonstrated in normal mammary tissue of mice (Haslam & Shyamala, 1979) and their relative dis¬ tribution has been biochemically studied in tissue components (Haslam & Shyamala, 1981) .
In these reports of progestagen binding in target tissues, promegestone, a potent synthetic progestagen, was used because it presents certain distinct advantages over progesterone. It binds with greater affinity to progestagen receptors and forms a more slowly dissociating complex with the progesterone receptor than does progesterone. Moreover, promegestone does not bind to corticosteroid-binding globulin (Philibert & Raynaud, 1974; Raynaud, 1977) .
We have previously described the precise anatomical distribution of receptor sites for progestagens in the brain and the genital tract of the guinea-pig after injection of [3H]progesterone (Warembourg & Milgrom, 1971 ; Warembourg, 1974 Warembourg, , 1978a and of the rat after injection of [3H]-promegestone (Warembourg, 1978b, c The details of the radioautographic procedure have been described elsewhere (Warembourg 1974 (Warembourg , 1976 (Fig. 5 ) and the luminal epithelium (Fig. 6) . 660. Fig. 7 Fig. 8 ). In the connective tissue of the lamina propria, subjacent to the vaginal epithelium, most scattered cells were heavily labelled (PI. 3, Fig. 9 ). Radioactivity was found in the stratified squamous epithelium, especially in the nuclei of the basal layer with a rapid decrease from the basal region to the surface.
Mammary glands
Although silver grains were seen distributed diffusely over different structures, most of the radioactivity was concentrated in nuclei of the epithelial cells of the ducts (PI. 3, Fig. 10 ). The basal cells of the sparse epithelium showed more labelling than the superficial cells. In our radioauto¬ grams, no selective subcellular retention of radioactivity was noted in the connective and adipose tissues. However, in methyl green-pyronin-stained cryostat sections it was difficult to identify the connective tissue precisely because of the predominance of fat cells. Therefore involvement of these cells in concentrating hormone cannot be definitely excluded.
Competition experiments
After preinjection of an excess of unlabelled promegestone there was a clearly displaceable nuclear concentration of radioactivity in the cells of the above tissues. On the other hand, in the presence of non-radioactive testosterone no consistent change was observed in the nuclear labelling of hypothalamic regions and cell types of the genital tract.
Discussion
The present radioautographic data describe the topographical distribution of progestagen target cells obtained with [3H] promegestone. Since the nuclear uptake observed in these cells can be inhibited by simultaneous treatment with unlabelled promegestone but very much less so by testo¬ sterone, the results suggest that the radioactivity represented promegestone or a biologically active metabolite and that the capacity of these cells to bind hormone is limited.
In the brains of oestrogen-treated and ovariectomized animals, the mediobasal hypothalamus and the preoptic area were most heavily labelled. The uterine tissues showed varied degrees of uptake, with the glandular and luminal epithelial cells containing less label than the stromal cells and smooth muscle fibres. The pattern of progestagen uptake was very similar to the patterns seen in rodents, i.e. guinea-pig after [3H]progesterone injection (Warembourg & Milgrom, 1971 ; Sar & Stumpf, 1973 , 1974 Warembourg, 1974 Warembourg, , 1978a ) and rat after [3H]promegestone injection (Warembourg, 1978b, c (Warembourg, 1977) . The rostral distribution of progestagen target cells also overlaps partly with the location of LH-RH secreting neurones in the galago (Barry, 1980) . Based on these observations, progestagen-binding sites are localized in key neuronal regions implicated in the control of gonadotrophin secretion and of sexual behaviour.
High concentrations of radioactivity were localized in the glandular epithelial cells of the mammary glands. This agrees well with binding studies, using [3H] promegestone in the normal mouse mammary gland, of Haslam & Shyamala (1979 who report that most of the progesterone receptors are present only in the glandular epithelium and that the oestrogenic regulation of these receptors appears to be restricted to the epithelial component. It is known that the effect of oestrogen and progestagen is important in the regulation of epithelial cell proliferation and the differentiation of the mammary tissue. This work was supported by the I.N.S.E.R.M.
